AbbVie (ABBV) Return on Sales [ROS] (2012 - 2026)
AbbVie (ABBV) reported Return on Sales [ROS] of 36.01% for Q3 2026, up 23.94 percentage points from 12.07% a year earlier but down 1.85 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, AbbVie's Return on Sales [ROS] came in at 32.16%, up 17.01 percentage points year-over-year; for FY2025, it was 24.65%, up 8.43 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of -0.16 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 16.22% in FY2024 (-7.27 pp), 23.49% in FY2023 (-7.72 pp), 31.21% in FY2022 (-0.69 pp) and 31.89% in FY2021 (+7.09 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -9.87% in Q4 2024 and a high of 37.86% in Q2 2026.
- Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +3.57 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2025 (a gain of 37.21 percentage points); the low point was Q4 2024 (a drop of 32.21 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 37.86% (Q2 2026), 26.60% (Q1 2026) and 27.34% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.01% |
| Jun 30, 2026 | 37.86% |
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 31.73% |
| Mar 31, 2025 | 27.98% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | 26.49% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 22.73% |
| Dec 31, 2023 | 22.34% |
| Sep 30, 2023 | 16.38% |
| Jun 30, 2023 | 32.55% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | 31.08% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 34.84% |
| Dec 31, 2021 | 34.09% |
API Access
AbbVie Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();